PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial, page-61

  1. 1,149 Posts.
    lightbulb Created with Sketch. 201
    When we are raking billions in royalties I don’t think anyone will remember this CR. In fact we will probably celebrating their vision to secure our path to commercialisation.

    On the road to the holy grail!

    I have had two bottles of champagne to celebrate today’s outcome. What a great day, well done to all believers.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.